Experts in the pharmaceutical industry are hopeful that this sustained bolus of new medicines is evidence that drug companies are coming out of a severe innovation drought over the last decade that saw the number of new medicines fall to little more than half its current level.

FORBES: New Drug Approval Rate At Near-Record High, FDA Says